MidFirst Bank

SEC CIK: 0002077076
Latest filing: Aug 7, 2026

SEC filings (opens in a new tab)

VRTX holding history

Vertex Pharmaceuticals Inc in every 13F filed by MidFirst Bank, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VRTX overview All 13F holders of VRTX Full Q2 2026 holdings

Shares (Q2 2026): 138
Value: $68.5K
% of portfolio: <0.1%
Quarters held: 3; Since Q4 2025

Holdings of VRTX by MidFirst Bank, by quarter
Quarter	Shares	Value	% of portfolio	Share change	Action	All holders
Q2 2026	138	$68.5K	<0.1%	+28+25.5%	Added	Holders
Q1 2026	110	$49.1K	<0.1%	−21−16.0%	Reduced	Holders
Q4 2025	131	$59.4K	<0.1%	–	No prior filing	Holders